TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Moberg Pharma AB
Closing information (x1000 NOK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 196 | 0 | 52,891 |
Financial expenses | 68 | 234 | 2,722 |
Earnings before taxes | -18,457 | -19,475 | 14,072 |
EBITDA | -16,690 | -16,721 | 20,732 |
Total assets | 533,895 | 439,717 | 503,455 |
Current assets | 120,850 | 102,062 | 174,754 |
Current liabilities | 25,337 | 15,153 | 84,001 |
Equity capital | 504,724 | 423,296 | 406,333 |
- share capital | 9,295 | 4,296 | 1,905 |
Employees (average) | 8 | 8 | 11 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 94.5% | 96.3% | 80.7% |
Turnover per employee | 24 | 0 | 4,808 |
Profit as a percentage of turnover | -9416.8% | 26.6% | |
Return on assets (ROA) | -3.4% | -4.4% | 3.3% |
Current ratio | 477.0% | 673.5% | 208.0% |
Return on equity (ROE) | -3.7% | -4.6% | 3.5% |
Change turnover | 196 | -49,237 | 36,597 |
Change turnover % | -100% | 225% | |
Chg. No. of employees | 0 | -3 | -16 |
Chg. No. of employees % | 0% | -27% | -59% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.